SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2350
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers ; volume:16 ; number:1 ; day:21 ; month:8 ; year:2015 ; pages:1-15 ; date:12.2015
BMC medical genetics ; 16, Heft 1 (21.8.2015), 1-15, 12.2015
- Urheber
-
Okamoto, Kanako
- Beteiligte Personen und Organisationen
-
Tsunematsu, Ryosuke
Tahira, Tomoko
Sonoda, Kenzo
Asanoma, Kazuo
Yagi, Hiroshi
Yoneda, Tomoko
Hayashi, Kenshi
Wake, Norio
Kato, Kiyoko
SpringerLink (Online service)
- DOI
-
10.1186/s12881-015-0216-8
- URN
-
urn:nbn:de:1111-201611057403
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:01 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Okamoto, Kanako
- Tsunematsu, Ryosuke
- Tahira, Tomoko
- Sonoda, Kenzo
- Asanoma, Kazuo
- Yagi, Hiroshi
- Yoneda, Tomoko
- Hayashi, Kenshi
- Wake, Norio
- Kato, Kiyoko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
The MDM2 gene family
Allele-specific binding (ASB) analyzer for annotation of allele-specific binding SNPs
Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
MDM2 as a chromatin modifier
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
MDM2- an indispensable player in tumorigenesis
Evolution of the p53-MDM2 pathway
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
Allele-specific expression assays using Solexa
Allele-specific disparity in breast cancer
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
The MDM2 gene family
Allele-specific binding (ASB) analyzer for annotation of allele-specific binding SNPs
Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
MDM2 as a chromatin modifier
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
MDM2- an indispensable player in tumorigenesis
Evolution of the p53-MDM2 pathway
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
Allele-specific expression assays using Solexa
Allele-specific disparity in breast cancer
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells
The MDM2 gene family
Allele-specific binding (ASB) analyzer for annotation of allele-specific binding SNPs
Inhibition of MDM2 homodimerization by XIAP IRES stabilizes MDM2, influencing cancer cell survival
MDM2 as a chromatin modifier
MDM2 SNP309 polymorphism contributes to endometrial cancer susceptibility: evidence from a meta-analysis
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
MDM2- an indispensable player in tumorigenesis
Evolution of the p53-MDM2 pathway
MDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer risk
Allele-specific expression assays using Solexa